Disclosure Plus

ABLE C&C, Riding the K-Beauty Craze, Sees Second-Quarter Operating Profit 'Soar' 53%

Company Reports 65.2 Billion Won in Revenue and 10.4 Billion Won in Operating Profit 'Target Set at the Start of the Year' Achieved: 75% of Revenue from Overseas Sales

KYUNG GYEYOUNG
2026-08-13 17:58:12
[Edaily Reporter KYUNG GYEYOUNG ] ABLE C&C, which operates brands such as Missha and A'pieu, achieved both revenue growth and improved profitability in the second quarter, riding the wave of K-Beauty’s popularity.

ABLE C&C(078520)The company announced on the 13th that its consolidated operating profit for the second quarter was 10.4 billion won, a 52.9% increase compared to the same period last year. Revenue for the same period rose 4.8% to 65.2 billion won. ABLE C&C explained that, excluding revenue from domestic company-owned stores that have been closed, the actual revenue growth rate was 24.5%.

Consolidated basis, unit: 100 million won, Source: ABLE C&C

Overseas operations drove the growth in performance. Overseas revenue rose 38% compared to the second quarter of last year, with its share of total revenue increasing to 75%. The company noted that it achieved its annual target for the share of overseas revenue—set at the beginning of the year—in the first half, indicating that its business structure, which has shifted from a domestic focus to a global one, is rapidly taking hold.

In fact, the export share of the cosmetics business segment has gradually expanded from 50.34% in 2024 to 53.59% in 2025 and to 69.80% in the first half of this year. Currently, ABLE C&C has expanded into 56 countries worldwide, including the establishment of local subsidiaries in Japan, the U.S., and China.

The growth drivers for its overseas business were the U.S. and Europe. Sales in the U.S. increased by 154% and in Europe by 48% compared to the second quarter of last year. In Europe, in particular, this growth was driven not only by increased sales from existing partners but also by the expansion of new offline distribution channels. The number of retail outlets in Europe doubled year-over-year, with the company securing placements at UK retailers such as Boots and Superdrug, Germany’s DM, and major Russian supermarkets. In the U.S., growth continued to be driven primarily by Amazon and TikTok Shop.

ABLE C&C also saw sales increase by 31% in China and 50% in the Middle East. In China, the expansion of cross-border e-commerce sales, centered on A’Pieu, played a significant role.

For its domestic business, the company reallocated its marketing and sales resources to high-growth channels. Sales on major online platforms such as Naver and 11st increased by 45.3% compared to the second quarter of last year. At Daiso, the company expanded its sales channels by launching the new A’pieu Hair Vinegar line. ABLE C&C explained that its strategy of selecting channels based on growth potential rather than scale is leading to improved profitability in its domestic business alongside the expansion of its global operations.

Shin Yu-jeong, CEO of ABLE C&C, emphasized, “These results demonstrate that the company’s transformation is not a one-time rebound but the result of a structural shift.” She added, “In the second half of the year, we will further expand our growth momentum in the U.S. and Europe and strengthen our focus on growth markets such as the Middle East and South America, while simultaneously creating new growth opportunities through a skincare-centric product portfolio and the expansion into new categories.”

In addition, ABLE C&C announced today that it has decided to cancel 1.05 million shares of treasury stock (representing a 4.0% stake). This amounts to a total of 10 billion won, and the cancellation is scheduled for the 31st of this month.

Economy

Corporation

IT·Science

Economy

[Market In] “Unlocking 134.1 Billion in Dormant Assets”… DaelimTrading’s ‘Complete Transformation’ for the First Time in 56 Years

Lee Sang-won, CEO of Daelim Trading ( DaelimTrading(006570) ), announced his ambition to significantly improve the company’s financial structure and revitalize its core business by realizing the value…
2026-09-10 04:52:04

Corporation

The ‘Data on Therapeutic Effects’ Kim Seung-won Claimed to Have Seen… A Closer Look at Genencell’s COVID-19 Paper Reveals Numerous Questions

Regarding the controversy over the request for expedited processing of clinical trials for Genencell’s COVID-19 treatment “ES16001,” Kim Seung-won, nominee for Minister of Justice, explained, “I revie…
2026-09-10 08:02:03

IT·Science

Hair-Loss Drug Hype Spreads to Korea as Hyundai Pharm and JW Shinyak Shares Soar [K-Bio Pulse]

(Image= ChatGPT) On Sept. 8, shares of Hyundai Pharmaceutical and JW Shinyak extended their rallies as U.S. investor enthusiasm over next-generation hair-loss treatments spilled over into South Ko…
2026-09-10 07:31:05